Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fesoterodine in OAB patients dissatisfied with tolterodine
NCT00425100Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2007
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of fesoterodine in overactive bladder (OAB), sponsored by Pfizer. Started Jan 2007; status: completed.
02
Drugs
fesoterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00425100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425100.